These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 34290239)
1. PPM1G promotes the progression of hepatocellular carcinoma via phosphorylation regulation of alternative splicing protein SRSF3. Chen D; Zhao Z; Chen L; Li Q; Zou J; Liu S Cell Death Dis; 2021 Jul; 12(8):722. PubMed ID: 34290239 [TBL] [Abstract][Full Text] [Related]
2. SCARB1-encoded circ _0029343 induces p73 splicing to promote growth and metastasis of hepatocellular carcinoma via miR-486-5p/SRSF3 axis. Zhu S; Cao S; Che J; Zhao L; Su Z; Li D; Pei R; Xu L; Ding Y; Zhou W J Biochem Mol Toxicol; 2024 Feb; 38(2):e23646. PubMed ID: 38345168 [TBL] [Abstract][Full Text] [Related]
3. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B. Ying H; Ji L; Xu Z; Fan X; Tong Y; Liu H; Zhao J; Cai X Cancer Lett; 2020 Mar; 473():13-24. PubMed ID: 31875525 [TBL] [Abstract][Full Text] [Related]
4. Prognostic and immunological potential of PPM1G in hepatocellular carcinoma. Lin YR; Yang WJ; Yang GW Aging (Albany NY); 2021 May; 13(9):12929-12954. PubMed ID: 33952716 [TBL] [Abstract][Full Text] [Related]
5. High expression of PPM1G is associated with the progression and poor prognosis of hepatocellular carcinoma. Xiong DL; Li Q; Wang H; Jin WL; Fan XM; Ma YY Cancer Biomark; 2022; 34(1):13-22. PubMed ID: 34366322 [TBL] [Abstract][Full Text] [Related]
6. PPM1G and its diagnostic, prognostic and therapeutic potential in HCC (Review). Zhang X; Wang H; Yuan Y; Zhang J; Yang J; Zhang L; He J Int J Oncol; 2024 Nov; 65(5):. PubMed ID: 39329206 [TBL] [Abstract][Full Text] [Related]
7. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A. Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761 [TBL] [Abstract][Full Text] [Related]
8. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes. Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429 [TBL] [Abstract][Full Text] [Related]
9. SRSF3 Depletion Leads to an Increase in SF3B4 Expression in SNU-368 HCC Cells. Lee J; Seo G; Hur W; Yoon SK; Nam SW; Lee JH Anticancer Res; 2020 Apr; 40(4):2033-2042. PubMed ID: 32234894 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA LINC02580 suppresses the invasion-metastasis cascade in hepatocellular carcinoma by targeting SRSF1. Xu L; Wang Z; Yin C; Pan F; Shi T; Tian Y Biochem Biophys Res Commun; 2020 Dec; 533(4):685-691. PubMed ID: 33168192 [TBL] [Abstract][Full Text] [Related]
11. PPM1G promotes the progression of lung adenocarcinoma by inhibiting p38 activation via dephosphorylation of MEK6. Chen J; Li J; Sun H; Hu T; Wang Y; Kang G; Cao M; Li X Carcinogenesis; 2023 May; 44(1):93-104. PubMed ID: 36349938 [TBL] [Abstract][Full Text] [Related]
12. Skipping of exon 10 in Shen L; Lei S; Zhang B; Li S; Huang L; Czachor A; Breitzig M; Gao Y; Huang M; Mo X; Zheng Q; Sun H; Wang F Theranostics; 2020; 10(13):5719-5735. PubMed ID: 32483414 [TBL] [Abstract][Full Text] [Related]
13. SRSF3 and HNRNPH1 Regulate Radiation-Induced Alternative Splicing of Protein Arginine Methyltransferase 5 in Hepatocellular Carcinoma. Wen C; Tian Z; Li L; Chen T; Chen H; Dai J; Liang Z; Ma S; Liu X Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499164 [TBL] [Abstract][Full Text] [Related]
14. The role of XBP1s in the metastasis and prognosis of hepatocellular carcinoma. Wu S; Du R; Gao C; Kang J; Wen J; Sun T Biochem Biophys Res Commun; 2018 Jun; 500(3):530-537. PubMed ID: 29627568 [TBL] [Abstract][Full Text] [Related]
15. LTR retrotransposon-derived LncRNA LINC01446 promotes hepatocellular carcinoma progression and angiogenesis by regulating the SRPK2/SRSF1/VEGF axis. Wu Y; Wang J; Zhao J; Su Y; Li X; Chen Z; Wu X; Huang S; He X; Liang L Cancer Lett; 2024 Aug; 598():217088. PubMed ID: 38945203 [TBL] [Abstract][Full Text] [Related]
16. HOX Antisense lincRNA HOXA-AS2 Promotes Tumorigenesis of Hepatocellular Carcinoma. Wang F; Yang H; Deng Z; Su Y; Fang Q; Yin Z Cell Physiol Biochem; 2016; 40(1-2):287-296. PubMed ID: 27855366 [TBL] [Abstract][Full Text] [Related]
17. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2. Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796 [TBL] [Abstract][Full Text] [Related]
18. Histone methyltransferase SETDB1 promotes cells proliferation and migration by interacting withTiam1 in hepatocellular carcinoma. Zhang Y; Huang J; Li Q; Chen K; Liang Y; Zhan Z; Ye F; Ni W; Chen L; Ding Y BMC Cancer; 2018 May; 18(1):539. PubMed ID: 29739365 [TBL] [Abstract][Full Text] [Related]
19. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein. Chen S; Wang L; Yao B; Liu Q; Guo C Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165 [TBL] [Abstract][Full Text] [Related]
20. Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression. Dong Y; Sun X; Zhang K; He X; Zhang Q; Song H; Xu M; Lu H; Ren R Bioengineered; 2021 Dec; 12(2):12967-12979. PubMed ID: 34939898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]